- Home
- / Caris Life Sciences
Caris Life Sciences
Revenue
$812 M
FY, 2025
Caris Life Sciences Summary
Company Summary
- Overview
- Caris Life Sciences is a molecular science company that provides cancer care services. It offers blood and tissue profiling, clinical discovery, trials, research and development, commercialization, precision oncology, and other solutions.
- Type
- Public
- Status
- Active
- Founded
- 2008
- HQ
- Irving, TX, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Chadi Nabhan, Chairman, Precision Oncology Alliance
David Spetzler, President, Chief Scientific Officer
Stephanie Thomas, Executive Vice President, Chief of Staff, Office of the CEO
Operating MetricsView all
Products and Services
4
Feb, 2023
Locations
6
Feb, 2023
Expertise Areas
8
Feb, 2023
LocationsView all
10 locations detected
Irving, TX HQ
United States
750 West John Carpenter Freeway Suite 800
Cambridge, MA
United States
245 Main Street
Irving, TX
United States
3600 W Royal Lane
New York, NY
United States
510 Madison Ave, 10th Floor
Phoenix, AZ
United States
4415 E. Cotton Center Blvd., Suite 100
Phoenix, AZ
United States
4550 S. 44th Place
Caris Life Sciences Financials
Summary Financials
- Revenue (Q1, 2026)
- $216.2M
- Net income (Q1, 2026)
- ($510.0K)
- Cash (Q1, 2026)
- $819.9M
- EBIT (Q1, 2026)
- $5.3M